Harte-Hanks, Inc. (HHS) Reports In-Line Q4 EPS
Harte-Hanks, Inc. (NYSE: HHS) reported Q4 EPS of $0.15, in-line with the analyst estimate of $0.15. Revenue for the quarter ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
